Fda Approves Trudhesa Nasal Spray To Treat Migraines
Trudhesa (generic name: dihydroergotamine mesylate) will be dispensed with a prescription through Trudhesa Direct, a pharmacy partnership and copay program that will deliver the medication to patients’ homes at no additional cost. “We are delighted with the approval of Trudhesa and are proud to offer the millions of Americans with migraine a non-oral, acute treatment option that may provide rapid, sustained, and consistent relief, even when taken late into a migraine attack,” Adrian Adams, chairman and chief executive officer of Impel NeuroPharma, said in a press release....